Scientific References GLP-1 receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued
But mainly, maybe this is a bad thing to say, but I think those that are probably taking it aren't going to the gym or training with a PT
FDA-Approved GLP-1R Obesity Medications (As of February, 2025) GLP-1 Treatments: Results, Side Effects, and Lifestyle Factors In terms of weight loss in people, GLP-1 drugs have demonstrated up to a 15-20% weight loss in individuals
The researchers concluded that the relative risk was increased by no more than 31% for those on GLP-1 agonists
The Food, Drug, and Cosmetics Act allows for compounding using bulk drug ingredients only if the drug is on the agency's 503B bulks list or the drug shortage list
Personalized Care for Your Best Results Choosing the right medication is a personal decision that depends on your health profile, preferences, and goals